ROYCE & ASSOCIATES LP - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$156,000
-83.7%
129,0000.0%0.00%
-80.0%
Q3 2015$958,000
-29.9%
129,000
-32.5%
0.01%
-16.7%
Q2 2015$1,366,000
-16.8%
191,0000.0%0.01%0.0%
Q1 2015$1,641,000
-34.4%
191,000
-23.9%
0.01%
-33.3%
Q4 2014$2,502,000251,0000.01%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders